148 related articles for article (PubMed ID: 30761133)
1. HLA-B and HLA-C Differ in Their Nanoscale Organization at Cell Surfaces.
Kennedy PR; Barthen C; Williamson DJ; Davis DM
Front Immunol; 2019; 10():61. PubMed ID: 30761133
[TBL] [Abstract][Full Text] [Related]
2. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
3. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
4. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
5. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
Parolini F; Biswas P; Serena M; Sironi F; Muraro V; Guizzardi E; Cazzoletti L; Scupoli MT; Gibellini D; Ugolotti E; Biassoni R; Beretta A; Malnati M; Romanelli MG; Zipeto D
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070683
[TBL] [Abstract][Full Text] [Related]
6. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
[TBL] [Abstract][Full Text] [Related]
7. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
8. Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density.
Almeida CR; Davis DM
J Immunol; 2006 Nov; 177(10):6904-10. PubMed ID: 17082605
[TBL] [Abstract][Full Text] [Related]
9. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.
Rasmussen M; Harndahl M; Stryhn A; Boucherma R; Nielsen LL; Lemonnier FA; Nielsen M; Buus S
J Immunol; 2014 Nov; 193(10):4790-802. PubMed ID: 25311805
[TBL] [Abstract][Full Text] [Related]
10. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
13. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
16. Stable Frequencies of HLA-C
Ziegler MC; Grañana FB; Garcia-Beltran WF; Schulze Zur Wiesch J; Hoffmann C; Rechtien A; Lunemann S; Altfeld M
Front Immunol; 2018; 9():2361. PubMed ID: 30386333
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells.
Davis DM; Mandelboim O; Luque I; Baba E; Boyson J; Strominger JL
J Exp Med; 1999 Apr; 189(8):1265-74. PubMed ID: 10209043
[TBL] [Abstract][Full Text] [Related]
18. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.
Vivian JP; Duncan RC; Berry R; O'Connor GM; Reid HH; Beddoe T; Gras S; Saunders PM; Olshina MA; Widjaja JM; Harpur CM; Lin J; Maloveste SM; Price DA; Lafont BA; McVicar DW; Clements CS; Brooks AG; Rossjohn J
Nature; 2011 Oct; 479(7373):401-5. PubMed ID: 22020283
[TBL] [Abstract][Full Text] [Related]
19. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.
Barber LD; Percival L; Valiante NM; Chen L; Lee C; Gumperz JE; Phillips JH; Lanier LL; Bigge JC; Parekh RB; Parham P
J Exp Med; 1996 Aug; 184(2):735-40. PubMed ID: 8760827
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.
Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M
J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
